Marlton Partners nominates directors to 180 Degree Capital board

Activist investor Marlton Partners, holding a 5.2% stake in 180 Degree Capital Corp. (TURN), has nominated four director candidates and compelled a special meeting for September 15, 2025. This action stems from Marlton's criticism of TURN's governance, including its failure to hold annual meetings, the five-month delay in a shareholder vote on the proposed sale to Mount Logan Capital Inc. (MLC), and over $6 million in deal-related and retention expenses, which represent 15.8% of TURN's Q1 net asset value, itself down 4.7%. Marlton seeks to realign TURN's strategic direction and expedite the MLC transaction, highlighting the need for improved shareholder oversight.

Analysis

Activist investor Marlton Partners L.P., which holds a 5.2% stake in 180 Degree Capital Corp. (TURN), is escalating its campaign by nominating four directors for a special shareholder meeting on September 15, 2025. The action is a direct response to what Marlton frames as significant governance failures, including the absence of an annual meeting since April 2024 and a five-month delay on a shareholder vote for the company's proposed sale to Mount Logan Capital Inc. (MLC). Marlton's critique is substantiated by financial claims, citing over $6 million in deal-related and retention costs, which it quantifies as 15.8% of TURN's first-quarter net asset value (NAV). This expenditure is particularly notable given the reported 4.7% decline in NAV during that same quarter. In sharp contrast, the proposed acquirer, MLC, is exhibiting significant strength, with its stock appreciating 37.5% over the past week and trading near its 52-week high, which the report attributes to market confidence. The activist's objective is to install a new slate of directors to expedite the MLC transaction and realign the company's strategy with shareholder interests.

Key Decisions for Investors

• Investors in TURN should closely monitor communications regarding the September 15 special meeting, as the outcome of the proxy contest will be pivotal for the board's composition and the stalled acquisition by MLC.
• The activist's claims of value erosion, specifically the 4.7% Q1 NAV decline and deal-related expenses constituting 15.8% of Q1 NAV, warrant a thorough re-evaluation of TURN's intrinsic value and management's performance.
• While the merger with the strongly performing MLC could unlock value for TURN shareholders, the protracted delays and board-level conflict introduce significant execution risk that must be factored into any assessment of the deal's probability of success.
• It is crucial to analyze the forthcoming proxy statements from both Marlton Partners and TURN's board to gain a balanced perspective before adjusting positions, as the current information is primarily from the activist's viewpoint.